SLC12A7 serves as a prognostic and immunotherapeutic biomarker identified by multi-omics analysis
Haoran Qu, Jun Sun, Guohao Wang, Shuhong Ding, Xiaoming Li · 2026
Read SLC12A7 serves as a prognostic and immunotherapeutic biomarker identified by multi-omics analysis by Haoran Qu, Jun Sun, Guohao Wang, Shuhong Ding, Xiaoming Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12883764.txt.
Description
Haoran Qu and four co-authors examine a membrane transporter gene across cancers in a 2026 paper. The gene helps keep cell salt balance in order, and odd levels of it have been reported in several tumors. Its role in cancer growth was still unclear. The team combined many data types to map it, with a focus on liver cancer.
The gene was turned up in many cancer types and linked to worse outcomes. Single-cell data placed it mostly in malignant cells, and its level tracked immune cell entry into tumors. Lab tests then showed it drives liver cancer cells to grow, move, and invade. The authors propose it as a marker and treatment target.
Catalog record
| CREATOR | Haoran Qu, Jun Sun, Guohao Wang, Shuhong Ding, Xiaoming Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |